[Skip to Navigation]
Observation
August 21, 2019

Refractory Generalized Granuloma Annulare Treated With Oral Apremilast

Author Affiliations
  • 1Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
JAMA Dermatol. 2019;155(11):1318-1320. doi:10.1001/jamadermatol.2019.2130

Granuloma annulare (GA) is a granulomatous necrobiotic dermatosis with a variable disease course and treatment response.1 Apremilast is an orally administered small-molecule drug that inhibits phosphodiesterase 4 (PDE4) and is used in the treatment of various inflammatory dermatoses, including chronic cutaneous sarcoidosis.2 Herein, we describe 4 patients with treatment-refractory generalized GA who responded favorably to apremilast.

×